nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—SLC6A4—Alzheimer's disease	0.544	1	CbGaD
Desvenlafaxine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0985	0.432	CbGbCtD
Desvenlafaxine—CYP3A4—Donepezil—Alzheimer's disease	0.0787	0.345	CbGbCtD
Desvenlafaxine—CYP3A4—Galantamine—Alzheimer's disease	0.0507	0.223	CbGbCtD
Desvenlafaxine—SLC6A2—locus ceruleus—Alzheimer's disease	0.0108	0.507	CbGeAlD
Desvenlafaxine—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00182	0.00942	CcSEcCtD
Desvenlafaxine—Depersonalisation—Rivastigmine—Alzheimer's disease	0.00182	0.00942	CcSEcCtD
Desvenlafaxine—Mania—Memantine—Alzheimer's disease	0.0018	0.00928	CcSEcCtD
Desvenlafaxine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00174	0.00896	CcSEcCtD
Desvenlafaxine—Cyclopentolate—BCHE—Alzheimer's disease	0.0017	0.413	CrCbGaD
Desvenlafaxine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.0017	0.00877	CcSEcCtD
Desvenlafaxine—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00159	0.00821	CcSEcCtD
Desvenlafaxine—SLC6A4—forebrain—Alzheimer's disease	0.00152	0.0713	CbGeAlD
Desvenlafaxine—Disturbance in attention—Memantine—Alzheimer's disease	0.00151	0.00779	CcSEcCtD
Desvenlafaxine—Disturbance in attention—Rivastigmine—Alzheimer's disease	0.00148	0.00762	CcSEcCtD
Desvenlafaxine—Bone disorder—Memantine—Alzheimer's disease	0.00145	0.00747	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.00142	0.00736	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Donepezil—Alzheimer's disease	0.00142	0.00735	CcSEcCtD
Desvenlafaxine—Venlafaxine—SLC6A4—Alzheimer's disease	0.00142	0.345	CrCbGaD
Desvenlafaxine—Bone disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00731	CcSEcCtD
Desvenlafaxine—SLC6A4—telencephalon—Alzheimer's disease	0.00139	0.0656	CbGeAlD
Desvenlafaxine—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00134	0.00691	CcSEcCtD
Desvenlafaxine—SLC6A2—forebrain—Alzheimer's disease	0.00133	0.0628	CbGeAlD
Desvenlafaxine—Urinary retention—Galantamine—Alzheimer's disease	0.00128	0.00662	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00123	0.00636	CcSEcCtD
Desvenlafaxine—SLC6A2—telencephalon—Alzheimer's disease	0.00123	0.0577	CbGeAlD
Desvenlafaxine—Libido decreased—Donepezil—Alzheimer's disease	0.00113	0.00582	CcSEcCtD
Desvenlafaxine—Hot flush—Donepezil—Alzheimer's disease	0.00112	0.00577	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00111	0.00572	CcSEcCtD
Desvenlafaxine—Weight decreased—Galantamine—Alzheimer's disease	0.00105	0.00544	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Donepezil—Alzheimer's disease	0.00105	0.00542	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00104	0.0054	CcSEcCtD
Desvenlafaxine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00104	0.00535	CcSEcCtD
Desvenlafaxine—Libido decreased—Memantine—Alzheimer's disease	0.00102	0.00528	CcSEcCtD
Desvenlafaxine—Hot flush—Memantine—Alzheimer's disease	0.00101	0.00524	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Memantine—Alzheimer's disease	0.00101	0.00519	CcSEcCtD
Desvenlafaxine—Libido decreased—Rivastigmine—Alzheimer's disease	0.001	0.00517	CcSEcCtD
Desvenlafaxine—Venlafaxine—CYP2D6—Alzheimer's disease	0.000998	0.242	CrCbGaD
Desvenlafaxine—Irritability—Donepezil—Alzheimer's disease	0.000997	0.00515	CcSEcCtD
Desvenlafaxine—Urinary retention—Donepezil—Alzheimer's disease	0.000993	0.00513	CcSEcCtD
Desvenlafaxine—Hot flush—Rivastigmine—Alzheimer's disease	0.000992	0.00512	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.000983	0.00508	CcSEcCtD
Desvenlafaxine—Epistaxis—Galantamine—Alzheimer's disease	0.00098	0.00506	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000964	0.00498	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000954	0.00493	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Memantine—Alzheimer's disease	0.000952	0.00492	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000948	0.0049	CcSEcCtD
Desvenlafaxine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000941	0.00486	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000932	0.00481	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000928	0.00479	CcSEcCtD
Desvenlafaxine—Hallucination—Galantamine—Alzheimer's disease	0.000928	0.00479	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000921	0.00476	CcSEcCtD
Desvenlafaxine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00092	0.00475	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000916	0.00473	CcSEcCtD
Desvenlafaxine—Urethral disorder—Galantamine—Alzheimer's disease	0.000914	0.00472	CcSEcCtD
Desvenlafaxine—Irritability—Memantine—Alzheimer's disease	0.000905	0.00468	CcSEcCtD
Desvenlafaxine—Urinary retention—Memantine—Alzheimer's disease	0.000902	0.00466	CcSEcCtD
Desvenlafaxine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000882	0.00456	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Memantine—Alzheimer's disease	0.000876	0.00452	CcSEcCtD
Desvenlafaxine—Eye disorder—Galantamine—Alzheimer's disease	0.000871	0.0045	CcSEcCtD
Desvenlafaxine—Tinnitus—Galantamine—Alzheimer's disease	0.000869	0.00449	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000866	0.00447	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000865	0.00447	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000857	0.00442	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000847	0.00438	CcSEcCtD
Desvenlafaxine—Angiopathy—Galantamine—Alzheimer's disease	0.000846	0.00437	CcSEcCtD
Desvenlafaxine—Immune system disorder—Galantamine—Alzheimer's disease	0.000842	0.00435	CcSEcCtD
Desvenlafaxine—Breast disorder—Rivastigmine—Alzheimer's disease	0.000838	0.00433	CcSEcCtD
Desvenlafaxine—SLC6A4—nervous system—Alzheimer's disease	0.000823	0.0387	CbGeAlD
Desvenlafaxine—Weight increased—Donepezil—Alzheimer's disease	0.000822	0.00424	CcSEcCtD
Desvenlafaxine—Mental disorder—Galantamine—Alzheimer's disease	0.000817	0.00422	CcSEcCtD
Desvenlafaxine—Weight decreased—Donepezil—Alzheimer's disease	0.000817	0.00422	CcSEcCtD
Desvenlafaxine—Malnutrition—Galantamine—Alzheimer's disease	0.000812	0.00419	CcSEcCtD
Desvenlafaxine—Tension—Galantamine—Alzheimer's disease	0.000796	0.00411	CcSEcCtD
Desvenlafaxine—Dysgeusia—Galantamine—Alzheimer's disease	0.000795	0.00411	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000794	0.0041	CcSEcCtD
Desvenlafaxine—SLC6A4—central nervous system—Alzheimer's disease	0.000792	0.0373	CbGeAlD
Desvenlafaxine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000789	0.00408	CcSEcCtD
Desvenlafaxine—Nervousness—Galantamine—Alzheimer's disease	0.000788	0.00407	CcSEcCtD
Desvenlafaxine—Vision blurred—Galantamine—Alzheimer's disease	0.000765	0.00395	CcSEcCtD
Desvenlafaxine—Tremor—Galantamine—Alzheimer's disease	0.00076	0.00393	CcSEcCtD
Desvenlafaxine—Epistaxis—Donepezil—Alzheimer's disease	0.000759	0.00392	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000755	0.0039	CcSEcCtD
Desvenlafaxine—Weight increased—Memantine—Alzheimer's disease	0.000746	0.00385	CcSEcCtD
Desvenlafaxine—Weight decreased—Memantine—Alzheimer's disease	0.000742	0.00383	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000739	0.00382	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000732	0.00378	CcSEcCtD
Desvenlafaxine—Weight increased—Rivastigmine—Alzheimer's disease	0.00073	0.00377	CcSEcCtD
Desvenlafaxine—Vertigo—Galantamine—Alzheimer's disease	0.000729	0.00377	CcSEcCtD
Desvenlafaxine—Syncope—Galantamine—Alzheimer's disease	0.000728	0.00376	CcSEcCtD
Desvenlafaxine—Weight decreased—Rivastigmine—Alzheimer's disease	0.000725	0.00375	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000725	0.00374	CcSEcCtD
Desvenlafaxine—SLC6A2—nervous system—Alzheimer's disease	0.000724	0.0341	CbGeAlD
Desvenlafaxine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00072	0.00372	CcSEcCtD
Desvenlafaxine—Hallucination—Donepezil—Alzheimer's disease	0.000719	0.00371	CcSEcCtD
Desvenlafaxine—Palpitations—Galantamine—Alzheimer's disease	0.000717	0.00371	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Memantine—Alzheimer's disease	0.000716	0.0037	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000714	0.00369	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000713	0.00369	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000709	0.00366	CcSEcCtD
Desvenlafaxine—Urethral disorder—Donepezil—Alzheimer's disease	0.000708	0.00366	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000705	0.00364	CcSEcCtD
Desvenlafaxine—Convulsion—Galantamine—Alzheimer's disease	0.000703	0.00363	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000701	0.00362	CcSEcCtD
Desvenlafaxine—Hypertension—Galantamine—Alzheimer's disease	0.000701	0.00362	CcSEcCtD
Desvenlafaxine—SLC6A2—central nervous system—Alzheimer's disease	0.000697	0.0328	CbGeAlD
Desvenlafaxine—Epistaxis—Memantine—Alzheimer's disease	0.000689	0.00356	CcSEcCtD
Desvenlafaxine—Anxiety—Galantamine—Alzheimer's disease	0.000689	0.00356	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000686	0.00355	CcSEcCtD
Desvenlafaxine—Dry mouth—Galantamine—Alzheimer's disease	0.000676	0.00349	CcSEcCtD
Desvenlafaxine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000674	0.00348	CcSEcCtD
Desvenlafaxine—Tinnitus—Donepezil—Alzheimer's disease	0.000674	0.00348	CcSEcCtD
Desvenlafaxine—Hallucination—Memantine—Alzheimer's disease	0.000653	0.00337	CcSEcCtD
Desvenlafaxine—Shock—Galantamine—Alzheimer's disease	0.000652	0.00337	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00065	0.00336	CcSEcCtD
Desvenlafaxine—Chills—Donepezil—Alzheimer's disease	0.000648	0.00335	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000648	0.00335	CcSEcCtD
Desvenlafaxine—Tachycardia—Galantamine—Alzheimer's disease	0.000647	0.00334	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000645	0.00333	CcSEcCtD
Desvenlafaxine—Skin disorder—Galantamine—Alzheimer's disease	0.000643	0.00332	CcSEcCtD
Desvenlafaxine—Urethral disorder—Memantine—Alzheimer's disease	0.000643	0.00332	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00064	0.00331	CcSEcCtD
Desvenlafaxine—Hallucination—Rivastigmine—Alzheimer's disease	0.000639	0.0033	CcSEcCtD
Desvenlafaxine—Alopecia—Donepezil—Alzheimer's disease	0.000639	0.0033	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000634	0.00327	CcSEcCtD
Desvenlafaxine—Mental disorder—Donepezil—Alzheimer's disease	0.000633	0.00327	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000631	0.00326	CcSEcCtD
Desvenlafaxine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000629	0.00325	CcSEcCtD
Desvenlafaxine—Malnutrition—Donepezil—Alzheimer's disease	0.000629	0.00325	CcSEcCtD
Desvenlafaxine—SLC6A4—brain—Alzheimer's disease	0.000629	0.0296	CbGeAlD
Desvenlafaxine—Erythema multiforme—Memantine—Alzheimer's disease	0.00062	0.0032	CcSEcCtD
Desvenlafaxine—Tension—Donepezil—Alzheimer's disease	0.000617	0.00319	CcSEcCtD
Desvenlafaxine—Dysgeusia—Donepezil—Alzheimer's disease	0.000616	0.00318	CcSEcCtD
Desvenlafaxine—Eye disorder—Memantine—Alzheimer's disease	0.000613	0.00317	CcSEcCtD
Desvenlafaxine—Tinnitus—Memantine—Alzheimer's disease	0.000612	0.00316	CcSEcCtD
Desvenlafaxine—Nervousness—Donepezil—Alzheimer's disease	0.000611	0.00316	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Memantine—Alzheimer's disease	0.000609	0.00315	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000607	0.00314	CcSEcCtD
Desvenlafaxine—Eye disorder—Rivastigmine—Alzheimer's disease	0.0006	0.0031	CcSEcCtD
Desvenlafaxine—Insomnia—Galantamine—Alzheimer's disease	0.000599	0.0031	CcSEcCtD
Desvenlafaxine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000598	0.00309	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000596	0.00308	CcSEcCtD
Desvenlafaxine—Angiopathy—Memantine—Alzheimer's disease	0.000595	0.00308	CcSEcCtD
Desvenlafaxine—Paraesthesia—Galantamine—Alzheimer's disease	0.000595	0.00307	CcSEcCtD
Desvenlafaxine—Vision blurred—Donepezil—Alzheimer's disease	0.000593	0.00306	CcSEcCtD
Desvenlafaxine—Immune system disorder—Memantine—Alzheimer's disease	0.000593	0.00306	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000591	0.00305	CcSEcCtD
Desvenlafaxine—Tremor—Donepezil—Alzheimer's disease	0.000589	0.00304	CcSEcCtD
Desvenlafaxine—Somnolence—Galantamine—Alzheimer's disease	0.000589	0.00304	CcSEcCtD
Desvenlafaxine—Chills—Memantine—Alzheimer's disease	0.000589	0.00304	CcSEcCtD
Desvenlafaxine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000582	0.00301	CcSEcCtD
Desvenlafaxine—Alopecia—Memantine—Alzheimer's disease	0.00058	0.003	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000578	0.00299	CcSEcCtD
Desvenlafaxine—Chills—Rivastigmine—Alzheimer's disease	0.000576	0.00298	CcSEcCtD
Desvenlafaxine—Decreased appetite—Galantamine—Alzheimer's disease	0.000576	0.00297	CcSEcCtD
Desvenlafaxine—Mental disorder—Memantine—Alzheimer's disease	0.000575	0.00297	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000572	0.00295	CcSEcCtD
Desvenlafaxine—Malnutrition—Memantine—Alzheimer's disease	0.000571	0.00295	CcSEcCtD
Desvenlafaxine—Fatigue—Galantamine—Alzheimer's disease	0.000571	0.00295	CcSEcCtD
Desvenlafaxine—Alopecia—Rivastigmine—Alzheimer's disease	0.000567	0.00293	CcSEcCtD
Desvenlafaxine—Constipation—Galantamine—Alzheimer's disease	0.000566	0.00293	CcSEcCtD
Desvenlafaxine—Vertigo—Donepezil—Alzheimer's disease	0.000565	0.00292	CcSEcCtD
Desvenlafaxine—Syncope—Donepezil—Alzheimer's disease	0.000564	0.00291	CcSEcCtD
Desvenlafaxine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000562	0.0029	CcSEcCtD
Desvenlafaxine—Tension—Memantine—Alzheimer's disease	0.00056	0.0029	CcSEcCtD
Desvenlafaxine—Dysgeusia—Memantine—Alzheimer's disease	0.000559	0.00289	CcSEcCtD
Desvenlafaxine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000559	0.00289	CcSEcCtD
Desvenlafaxine—Nervousness—Memantine—Alzheimer's disease	0.000555	0.00287	CcSEcCtD
Desvenlafaxine—SLC6A2—brain—Alzheimer's disease	0.000554	0.026	CbGeAlD
Desvenlafaxine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000553	0.00286	CcSEcCtD
Desvenlafaxine—Tension—Rivastigmine—Alzheimer's disease	0.000548	0.00283	CcSEcCtD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SYP—Alzheimer's disease	0.000548	0.0617	CbGpPWpGaD
Desvenlafaxine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000547	0.00283	CcSEcCtD
Desvenlafaxine—Convulsion—Donepezil—Alzheimer's disease	0.000545	0.00282	CcSEcCtD
Desvenlafaxine—Hypertension—Donepezil—Alzheimer's disease	0.000543	0.00281	CcSEcCtD
Desvenlafaxine—Nervousness—Rivastigmine—Alzheimer's disease	0.000543	0.0028	CcSEcCtD
Desvenlafaxine—Vision blurred—Memantine—Alzheimer's disease	0.000538	0.00278	CcSEcCtD
Desvenlafaxine—Tremor—Memantine—Alzheimer's disease	0.000535	0.00276	CcSEcCtD
Desvenlafaxine—Anxiety—Donepezil—Alzheimer's disease	0.000534	0.00276	CcSEcCtD
Desvenlafaxine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000527	0.00272	CcSEcCtD
Desvenlafaxine—Dry mouth—Donepezil—Alzheimer's disease	0.000524	0.00271	CcSEcCtD
Desvenlafaxine—Tremor—Rivastigmine—Alzheimer's disease	0.000523	0.0027	CcSEcCtD
Desvenlafaxine—Vertigo—Memantine—Alzheimer's disease	0.000513	0.00265	CcSEcCtD
Desvenlafaxine—Syncope—Memantine—Alzheimer's disease	0.000512	0.00265	CcSEcCtD
Desvenlafaxine—Shock—Donepezil—Alzheimer's disease	0.000505	0.00261	CcSEcCtD
Desvenlafaxine—Palpitations—Memantine—Alzheimer's disease	0.000505	0.00261	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000503	0.0026	CcSEcCtD
Desvenlafaxine—Vertigo—Rivastigmine—Alzheimer's disease	0.000502	0.00259	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Memantine—Alzheimer's disease	0.000502	0.00259	CcSEcCtD
Desvenlafaxine—Syncope—Rivastigmine—Alzheimer's disease	0.000501	0.00259	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000496	0.00256	CcSEcCtD
Desvenlafaxine—Convulsion—Memantine—Alzheimer's disease	0.000495	0.00256	CcSEcCtD
Desvenlafaxine—Palpitations—Rivastigmine—Alzheimer's disease	0.000494	0.00255	CcSEcCtD
Desvenlafaxine—Hypertension—Memantine—Alzheimer's disease	0.000493	0.00255	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000491	0.00254	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000488	0.00252	CcSEcCtD
Desvenlafaxine—Anxiety—Memantine—Alzheimer's disease	0.000485	0.0025	CcSEcCtD
Desvenlafaxine—Convulsion—Rivastigmine—Alzheimer's disease	0.000484	0.0025	CcSEcCtD
Desvenlafaxine—Hypertension—Rivastigmine—Alzheimer's disease	0.000482	0.00249	CcSEcCtD
Desvenlafaxine—Dry mouth—Memantine—Alzheimer's disease	0.000476	0.00246	CcSEcCtD
Desvenlafaxine—Asthenia—Galantamine—Alzheimer's disease	0.000475	0.00246	CcSEcCtD
Desvenlafaxine—Anxiety—Rivastigmine—Alzheimer's disease	0.000474	0.00245	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000472	0.00244	CcSEcCtD
Desvenlafaxine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000465	0.0024	CcSEcCtD
Desvenlafaxine—Insomnia—Donepezil—Alzheimer's disease	0.000464	0.0024	CcSEcCtD
Desvenlafaxine—Paraesthesia—Donepezil—Alzheimer's disease	0.000461	0.00238	CcSEcCtD
Desvenlafaxine—Shock—Memantine—Alzheimer's disease	0.000459	0.00237	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Memantine—Alzheimer's disease	0.000457	0.00236	CcSEcCtD
Desvenlafaxine—Somnolence—Donepezil—Alzheimer's disease	0.000456	0.00236	CcSEcCtD
Desvenlafaxine—Tachycardia—Memantine—Alzheimer's disease	0.000455	0.00235	CcSEcCtD
Desvenlafaxine—Diarrhoea—Galantamine—Alzheimer's disease	0.000453	0.00234	CcSEcCtD
Desvenlafaxine—Skin disorder—Memantine—Alzheimer's disease	0.000453	0.00234	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000451	0.00233	CcSEcCtD
Desvenlafaxine—Shock—Rivastigmine—Alzheimer's disease	0.000449	0.00232	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000447	0.00231	CcSEcCtD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—Alzheimer's disease	0.000447	0.0503	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Donepezil—Alzheimer's disease	0.000446	0.00231	CcSEcCtD
Desvenlafaxine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000445	0.0023	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000443	0.00229	CcSEcCtD
Desvenlafaxine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000443	0.00229	CcSEcCtD
Desvenlafaxine—Fatigue—Donepezil—Alzheimer's disease	0.000443	0.00229	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000441	0.00228	CcSEcCtD
Desvenlafaxine—Constipation—Donepezil—Alzheimer's disease	0.000439	0.00227	CcSEcCtD
Desvenlafaxine—Dizziness—Galantamine—Alzheimer's disease	0.000438	0.00226	CcSEcCtD
Desvenlafaxine—Insomnia—Memantine—Alzheimer's disease	0.000422	0.00218	CcSEcCtD
Desvenlafaxine—Vomiting—Galantamine—Alzheimer's disease	0.000421	0.00218	CcSEcCtD
Desvenlafaxine—Paraesthesia—Memantine—Alzheimer's disease	0.000419	0.00216	CcSEcCtD
Desvenlafaxine—Rash—Galantamine—Alzheimer's disease	0.000418	0.00216	CcSEcCtD
Desvenlafaxine—Dermatitis—Galantamine—Alzheimer's disease	0.000417	0.00216	CcSEcCtD
Desvenlafaxine—Headache—Galantamine—Alzheimer's disease	0.000415	0.00214	CcSEcCtD
Desvenlafaxine—Somnolence—Memantine—Alzheimer's disease	0.000414	0.00214	CcSEcCtD
Desvenlafaxine—Insomnia—Rivastigmine—Alzheimer's disease	0.000412	0.00213	CcSEcCtD
Desvenlafaxine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000409	0.00212	CcSEcCtD
Desvenlafaxine—Somnolence—Rivastigmine—Alzheimer's disease	0.000405	0.00209	CcSEcCtD
Desvenlafaxine—Decreased appetite—Memantine—Alzheimer's disease	0.000405	0.00209	CcSEcCtD
Desvenlafaxine—CYP3A4—nervous system—Alzheimer's disease	0.000403	0.019	CbGeAlD
Desvenlafaxine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000402	0.00208	CcSEcCtD
Desvenlafaxine—SLC6A4—Monoamine Transport—PVRL2—Alzheimer's disease	0.000402	0.0453	CbGpPWpGaD
Desvenlafaxine—Fatigue—Memantine—Alzheimer's disease	0.000402	0.00208	CcSEcCtD
Desvenlafaxine—Constipation—Memantine—Alzheimer's disease	0.000399	0.00206	CcSEcCtD
Desvenlafaxine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000396	0.00205	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000394	0.00203	CcSEcCtD
Desvenlafaxine—Nausea—Galantamine—Alzheimer's disease	0.000393	0.00203	CcSEcCtD
Desvenlafaxine—Fatigue—Rivastigmine—Alzheimer's disease	0.000393	0.00203	CcSEcCtD
Desvenlafaxine—Constipation—Rivastigmine—Alzheimer's disease	0.00039	0.00201	CcSEcCtD
Desvenlafaxine—CYP3A4—central nervous system—Alzheimer's disease	0.000388	0.0183	CbGeAlD
Desvenlafaxine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000378	0.00195	CcSEcCtD
Desvenlafaxine—Asthenia—Donepezil—Alzheimer's disease	0.000368	0.0019	CcSEcCtD
Desvenlafaxine—Diarrhoea—Donepezil—Alzheimer's disease	0.000351	0.00181	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—PVRL2—Alzheimer's disease	0.000346	0.0389	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Memantine—Alzheimer's disease	0.000343	0.00177	CcSEcCtD
Desvenlafaxine—Dizziness—Donepezil—Alzheimer's disease	0.000339	0.00175	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000336	0.00174	CcSEcCtD
Desvenlafaxine—Asthenia—Memantine—Alzheimer's disease	0.000334	0.00173	CcSEcCtD
Desvenlafaxine—Asthenia—Rivastigmine—Alzheimer's disease	0.000327	0.00169	CcSEcCtD
Desvenlafaxine—Vomiting—Donepezil—Alzheimer's disease	0.000326	0.00169	CcSEcCtD
Desvenlafaxine—Rash—Donepezil—Alzheimer's disease	0.000324	0.00167	CcSEcCtD
Desvenlafaxine—Dermatitis—Donepezil—Alzheimer's disease	0.000323	0.00167	CcSEcCtD
Desvenlafaxine—Headache—Donepezil—Alzheimer's disease	0.000322	0.00166	CcSEcCtD
Desvenlafaxine—Diarrhoea—Memantine—Alzheimer's disease	0.000319	0.00165	CcSEcCtD
Desvenlafaxine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000312	0.00161	CcSEcCtD
Desvenlafaxine—Dizziness—Memantine—Alzheimer's disease	0.000308	0.00159	CcSEcCtD
Desvenlafaxine—Nausea—Donepezil—Alzheimer's disease	0.000305	0.00158	CcSEcCtD
Desvenlafaxine—Dizziness—Rivastigmine—Alzheimer's disease	0.000302	0.00156	CcSEcCtD
Desvenlafaxine—SLC6A4—Monoamine Transport—ACHE—Alzheimer's disease	0.000301	0.0339	CbGpPWpGaD
Desvenlafaxine—Vomiting—Memantine—Alzheimer's disease	0.000296	0.00153	CcSEcCtD
Desvenlafaxine—Rash—Memantine—Alzheimer's disease	0.000294	0.00152	CcSEcCtD
Desvenlafaxine—Dermatitis—Memantine—Alzheimer's disease	0.000294	0.00152	CcSEcCtD
Desvenlafaxine—Headache—Memantine—Alzheimer's disease	0.000292	0.00151	CcSEcCtD
Desvenlafaxine—Vomiting—Rivastigmine—Alzheimer's disease	0.00029	0.0015	CcSEcCtD
Desvenlafaxine—Rash—Rivastigmine—Alzheimer's disease	0.000288	0.00149	CcSEcCtD
Desvenlafaxine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000287	0.00148	CcSEcCtD
Desvenlafaxine—Headache—Rivastigmine—Alzheimer's disease	0.000286	0.00148	CcSEcCtD
Desvenlafaxine—Nausea—Memantine—Alzheimer's disease	0.000277	0.00143	CcSEcCtD
Desvenlafaxine—Nausea—Rivastigmine—Alzheimer's disease	0.000271	0.0014	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—ACHE—Alzheimer's disease	0.000259	0.0292	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000238	0.0268	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—Alzheimer's disease	0.000236	0.0266	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.00023	0.0259	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000196	0.022	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000163	0.0184	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000151	0.017	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000151	0.0169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000141	0.0158	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000129	0.0145	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000129	0.0145	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000125	0.014	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.000123	0.0138	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000119	0.0134	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000113	0.0127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000112	0.0127	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000109	0.0123	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000104	0.0117	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000103	0.0116	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000101	0.0114	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—Alzheimer's disease	0.000101	0.0113	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	9.41e-05	0.0106	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	9.23e-05	0.0104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	9.05e-05	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	8.87e-05	0.00999	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	8.81e-05	0.00991	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	8.69e-05	0.00978	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—Alzheimer's disease	8.65e-05	0.00974	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	8.58e-05	0.00966	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	8.38e-05	0.00944	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	8.29e-05	0.00933	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	7.65e-05	0.00861	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	7.58e-05	0.00854	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	7.58e-05	0.00854	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CST3—Alzheimer's disease	7.54e-05	0.00849	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CHRNB2—Alzheimer's disease	7.54e-05	0.00849	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	7.32e-05	0.00824	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—Alzheimer's disease	7.3e-05	0.00822	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	7.14e-05	0.00804	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A4—Alzheimer's disease	7.07e-05	0.00796	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CRH—Alzheimer's disease	6.85e-05	0.00771	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	6.5e-05	0.00732	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NPS—Alzheimer's disease	6.49e-05	0.00731	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—Alzheimer's disease	6.28e-05	0.00707	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—Alzheimer's disease	6.11e-05	0.00688	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	5.82e-05	0.00656	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	5.66e-05	0.00637	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	5.57e-05	0.00627	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—AGER—Alzheimer's disease	5.49e-05	0.00618	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	5.43e-05	0.00612	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	5.33e-05	0.006	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NGFR—Alzheimer's disease	5.31e-05	0.00598	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	5.3e-05	0.00597	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—Alzheimer's disease	5.26e-05	0.00592	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	5.26e-05	0.00592	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	5.02e-05	0.00565	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	4.83e-05	0.00543	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	4.78e-05	0.00538	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	4.76e-05	0.00535	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—AGER—Alzheimer's disease	4.72e-05	0.00532	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	4.51e-05	0.00508	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	4.26e-05	0.0048	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PRKCG—Alzheimer's disease	4.21e-05	0.00474	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	3.91e-05	0.0044	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	3.85e-05	0.00434	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.82e-05	0.0043	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	3.79e-05	0.00427	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	3.74e-05	0.00421	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—LEP—Alzheimer's disease	3.63e-05	0.00409	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—Alzheimer's disease	3.38e-05	0.00381	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	3.23e-05	0.00363	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	3.17e-05	0.00356	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARG—Alzheimer's disease	3.16e-05	0.00356	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—GSK3B—Alzheimer's disease	3.14e-05	0.00354	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CREB1—Alzheimer's disease	3.12e-05	0.00351	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	3.06e-05	0.00344	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.83e-05	0.00319	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.83e-05	0.00319	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.83e-05	0.00318	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.41e-05	0.00271	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.4e-05	0.0027	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	2.32e-05	0.00261	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	2.26e-05	0.00255	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.12e-05	0.00239	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.06e-05	0.00231	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	2e-05	0.00225	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	1.71e-05	0.00193	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.68e-05	0.0019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	1.68e-05	0.00189	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.66e-05	0.00187	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.66e-05	0.00187	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	1.48e-05	0.00167	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	1.35e-05	0.00153	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	9.72e-06	0.00109	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA4—Alzheimer's disease	8.27e-06	0.00093	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	7.77e-06	0.000875	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	7.37e-06	0.000829	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	7.03e-06	0.000791	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	6.74e-06	0.000758	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	6.49e-06	0.00073	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ND1—Alzheimer's disease	6.26e-06	0.000705	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.04e-06	0.000454	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.04e-06	0.000454	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.87e-06	0.000436	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.73e-06	0.000419	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.6e-06	0.000405	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.13e-06	0.000352	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.09e-06	0.000348	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.93e-06	0.00033	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.93e-06	0.00033	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.88e-06	0.000324	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.73e-06	0.000307	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.57e-06	0.00029	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.49e-06	0.000281	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.15e-06	0.000242	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.14e-06	0.000241	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.96e-06	0.00022	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.76e-06	0.000198	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.65e-06	0.000185	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.64e-06	0.000185	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.63e-06	0.000183	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.43e-06	0.000161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.4e-06	0.000158	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.23e-06	0.000138	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.12e-06	0.000127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.65e-07	6.36e-05	CbGpPWpGaD
